Cardio3 BioSciences SA of Belgium is to sell shares valued at €25 million to Medisun International Ltd of Hong Kong in a two-part deal that will also see it participate in a joint venture with ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News Regenerative Medicine
